Saou-Hsing  Liou

Dr. Saou-Hsing Liou


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2015 in Journal of Nanoparticle Research
Verified
Journal Article
Closed access
PDF file
SLSaou-Hsing Liou
Saou-Hsing Liou
CTCandace S. J. Tsai
Candace S. J. Tsai
DPDaniela Pelclova
Daniela Pelclova
MSMary K. Schubauer-Berigan
Mary K. Schubauer-Berigan
PSPaul A. Schulte
Paul A. Schulte

3 December 2013 in Nanotoxicology
Verified
Journal Article
Closed access
HLHui-Yi Liao
Hui-Yi Liao
YCYu-Teh Chung
Yu-Teh Chung
CLChing-Huang Lai
Ching-Huang Lai
SWShu-Li Wang
Shu-Li Wang
HCHung-Che Chiang
Hung-Che Chiang
SLSaou-Hsing Liou
Saou-Hsing Liou
The aim of this study was to identify the health hazards and possible exposure surveillance markers of workers exposed to nanoparticles during manufacturing and application in comparison to a group of unexposed workers. For this longitudinal study, we recruited 158 nanomaterial-handling workers and 104 non-exposed workers from 14 manufacturing plants in Taiwan (baseline). Among them, 124 nanomaterial-handling workers and 77 unexposed workers were monitored 6 months later. We investigated pulmonary and cardiovascular disease markers, inflammation and oxidative stress markers, antioxidant enzymes and genotoxicity markers. Antioxidant enzymes (superoxide dismutase, glutathione peroxidase) and cardiovascular markers (vascular cell adhesion molecule, paraoxonase) were significantly associated with nanomaterial-handling during the 6-month follow-up period. In addition, the small airway damage marker (Clara cell protein 16) and lung function test parameters were also significantly associated with handling nanomaterials. The study markers and lung function tests are possible markers that could be useful for surveillance of nanomaterial-handling workers.

4 July 2012 in Journal of Nanoparticle Research
Verified
Journal Article
Closed access
PDF file
SLSaou-Hsing Liou
Saou-Hsing Liou
TTTsui-Chun Tsou
Tsui-Chun Tsou
SWShu-Li Wang
Shu-Li Wang
LLLih-Ann Li
Lih-Ann Li
HCHung-Che Chiang
Hung-Che Chiang
YCYu-Teh Chung
Yu-Teh Chung

12 September 2012 in Journal of Exposure Science & Environmental Epidemiology
Verified
Journal Article
Open access
PDF file
Ching-huang LaiChing-huang Lai
Ching-huang Lai
Jouni J.K. JaakkolaJouni J.K. Jaakkola
Jouni J.K. Jaakkola
CCChien-Yi Chuang
Chien-Yi Chuang
SLSaou-Hsing Liou
Saou-Hsing Liou
Shih-Chun Candice LungShih-Chun Candice Lung
Shih-Chun Candice Lung
PSPaul T Strickland
Paul T Strickland
Cooking oil fumes (COF) contain polycyclic aromatic hydrocarbons (PAHs), heterocyclic aromatic amines, benzene, and formaldehyde, which may cause oxidative damages to DNA and lipids. We assessed the relations between exposure to COF and subsequent oxidative DNA damage and lipid peroxidation among military cooks and office-based soldiers. The study population, including 61 Taiwanese male military cooks and a reference group of 37 office soldiers, collected urine samples pre-shift of the first weekday and post-shift of the fifth workday. We measured airborne particulate PAHs in military kitchens and offices and concentrations of urinary 1-OHP, a biomarker of PAH exposure, urinary 8-hydroxydeoxyguanosine (8-OHdG), a biomarkers of oxidative DNA damage, and urinary isoprostane (Isop). Airborne particulate PAHs levels in kitchens significantly exceeded those in office areas. The concentrations of urinary 1-OHP among military cooks increased significantly after 5 days of exposure to COF. Using generalized estimating equation analysis adjusting for confounding, a change in log(8-OHdG) and log(Isop) were statistically significantly related to a unit change in log(1-OHP) (regression coefficient (β), β=0.06, 95% CI 0.001–0.12) and (β=0.07, 95% CI 0.001–0.13), respectively. Exposure to PAHs, or other compounds in cooking oil fumes, may cause both oxidative DNA damage and lipid peroxidation.

Verified
Journal Article
Open access
PDF file
WWWei-Te Wu
Wei-Te Wu
HLHui-Yi Liao
Hui-Yi Liao
YCYu-Teh Chung
Yu-Teh Chung
WLWan-Fen Li
Wan-Fen Li
TTTsui-Chun Tsou
Tsui-Chun Tsou
SLSaou-Hsing Liou
Saou-Hsing Liou
Fractional exhaled nitric oxide (FENO) measurement is a useful diagnostic test of airway inflammation. However, there have been few studies of FENO in workers exposed to nanomaterials. The purpose of this study was to examine the effect of nanoparticle (NP) exposure on FENO and to assess whether the FENO is increased in workers exposed to nanomaterials (NM). In this study, both exposed workers and non-exposed controls were recruited from NM handling plants in Taiwan. A total of 437 subjects (exposed group = 241, non-exposed group = 196) completed the FENO and spirometric measurements from 2009–2011. The authors used a control-banding (CB) matrix to categorize the risk level of each participant. In a multivariate linear regression analysis, this study found a significant association between risk level 2 of NP exposure and FENO. Furthermore, asthma, allergic rhinitis, peak expiratory flow rate (PEFR), and NF-κB were also significantly associated with FENO. When the multivariate logistic regression model was adjusted for confounders, nano-TiO2 in all of the NM exposed categories had a significantly increased risk in FENO > 35 ppb. This study found associations between the risk level of NP exposure and FENO (particularly noteworthy for Nano-TiO2). Monitoring FENO in the lung could open up a window into the role nitric oxide (NO) may play in pathogenesis.

26 June 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
WWWei-Te Wu
Wei-Te Wu
STSu-Shan Tsai
Su-Shan Tsai
TSTung-Sheng Shih
Tung-Sheng Shih
MLMing-Hsiu Lin
Ming-Hsiu Lin
TCTzu-Chieh Chou
Tzu-Chieh Chou
SLSaou-Hsing Liou
Saou-Hsing Liou
The purpose of this study was to investigate the association between apnea-hypopnea index (AHI) and metabolic markers and whether the elevated risk of Metabolic Syndrome (MetS) is related to Obstructive Sleep Apnea (OSA). This cross-sectional study recruited 246 male bus drivers from one transportation company in Taiwan. Each participant was evaluated by a polysomnography (PSG) test and by blood lipids examination. Severity of OSA was categorized according to the apnea-hypopnea index (AHI). The results showed that a 73.3% prevalence of MetS in OSA (AHI > 15) and a 80.0% prevalence of MetS in severe OSA (AHI > 30) were found. After adjusting for confounding variables, an increased level of Body-Mass Index (BMI) and two non-MetS cardiovascular risk factors, total cholesterol/HDL-C ratio and TG/HDL-C ratio was significantly associated with AHI in subjects with severe OSA. MetS was about three times to be present in subjects with severe OSA, even adjusted for BMI. The findings showed a high prevalence of MetS in OSA among professional drivers, especially in the severe group category. BMI was the major contributing factor to OSA. However, the present study did not find a sensitive clinical marker of a detrimental metabolic profile in OSA patients.